Australian molecular diagnostics firm Genetic Signatures formed a partnership with Tecan and Repado to integrate infectious disease testing with automated liquid handling and regulatory compliant software. The collaboration aims to streamline syndromic testing workflows from sample to result, enhancing scalability and quality. The initiative follows Genetic Signatures’ FDA clearance of its gastrointestinal panel and efforts to expand its molecular diagnostic menu.